A versatile drug delivery system targeting senescent cells
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Senescent cells accumulate in multiple aging‐associated diseases, and eliminating these cells has recently emerged as a promising therapeutic approach. Here, we take advantage of the high lysosomal β‐galactosidase activity of senescent cells to design a drug delivery system based on the encapsulation of drugs with galacto‐oligosaccharides. We show that gal‐encapsulated fluorophores are preferentially released within senescent cells in mice. In a model of chemotherapy‐induced senescence, gal‐encapsulated cytotoxic drugs target senescent tumor cells and improve tumor xenograft regression in combination with palbociclib. Moreover, in a model of pulmonary fibrosis in mice, gal‐encapsulated cytotoxics target senescent cells, reducing collagen deposition and restoring pulmonary function. Finally, gal‐encapsulation reduces the toxic side effects of the cytotoxic drugs. Drug delivery into senescent cells opens new diagnostic and therapeutic applications for senescence‐associated disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“One approach stems from the increase in lysosomal mass and senescence-associated β-galactosidase activity in many senescent cells, whereby galacto-oligosaccharide-coated nanoparticles and β-galactosidase-activated prodrugs appear to eliminate at least some of these cells92,93.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“Nanoparticles containing either fluorophores or cytotoxic agents coated with galacto-oligosaccharides were found to preferentially deliver cytotoxic cargo to senescent cells because of the higher level of SA-β-gal activity in these cells218.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [218]
The cited source says what the claim attributes to it.
In the citing paper
“A senescence transcriptional signature could enable rapid detection of senescent cells, and multiple such gene sets have been described132–136,139.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“Galacto-oligosaccharide encapsulated nanoparticles (GalNP) containing cytotoxic or senolytic drugs (Muñoz-Espín et al. 2018) and galactose-derived prodrugs display senolytic properties (González-Gualda et al. 2020; Guerrero et al. 2020)”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Muñoz-Espín et al. 2018
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Spatial omics has not yet been used extensively for senescence research but is in development132–136.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [134]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
InfluentialThe Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialUltrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialOrdered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275 · cited 4×
“For the synthesis of the mesoporous silica MCM-41 scaffolds (Kresge et al, 1992), N-cetyltrimethylammonium bromide (CTAB, Sigma, #H6269) was first dissolved in 480 ml of deionized water at 2.74 mM.”
BackgroundMethodInfluentialTrapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116 · cited 1×
“0.10 (Trapnell et al, 2012), Bowtie 1.0.0 (Langmead et al, 2009) and Samtools 0.1.19.0 (Li et al, 2009); and transcripts assembly, abundances estimation, and differential expression were calculated with DESeq2 (Love et al, 2014).”
MethodInfluentialA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218 · cited 1×
“In this regard, it is relevant to mention that macrophages are known to metabolize nanoparticles (Wilhelm et al, 2016) and can present SAbGal activity without actually being senescent (Hall et al, 2017).”
BackgroundNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 1×
“Published under the terms of the CC BY 4.0 license EMBO Molecular Medicine 10: e9355 | 2018 1 of 18 processes associated with chemotherapy, and extends longevity (Baker et al, 2016; Childs et al, 2016; Demaria et al, 2017).”
MethodInfluentialCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Self-citationThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 3×
“Importantly, senescent cells present vulnerabilities to particular small molecule inhibitors, known as “senolytics”, that trigger apoptosis preferentially in senescent cells (Zhu et al, 2015).”
Background
Cited by
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Senolytic drugs: from discovery to translation
Kirkland, J. L., & Tchkonia, T. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13141 · Cited by 1,227
Senescence and the SASP: many therapeutic avenues
Birch, J., & Gil, J. (2020) · Genes & Development · doi:10.1101/gad.343129.120 · Cited by 1,177
Cellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134
Self-citationExploiting senescence for the treatment of cancer
Wang, L., Lankhorst, L., & Bernards, R. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00450-9 · Cited by 867
Metadata
- Authors
- Muñoz‐Espín, D., Rovira, M., Galiana, I., Giménez, C., Lozano‐Torres, B., Paez‐Ribes, M., Llanos, S., Chaib, S., Muñoz‐Martín, M., Ucero, A. C., Garaulet, G., Mulero, F., Dann, S. G., VanArsdale, T., Shields, D. J., Bernardos, A., Murguía, J. R., Martínez‐Máñez, R., & Serrano, M.
- Affiliations
- University of Cambridge (GB)
- Spanish National Cancer Research Centre (ES)
- Universitat de València (ES)
- Pfizer (United States) (US)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Muñoz‐Espín, Daniel
- Serrano, Manuel
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2018-07-16
- Volume
- 10
- Issue
- 9
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC6127887
- OpenAlex
- W2884253843
- Cited by
- 339
- References
- 64
- Citations by year
- 2026: 33 · 2025: 48 · 2024: 52 · 2023: 45 · 2022: 48 · 2021: 28 · 2020: 52 · 2019: 31 · 2018: 2
- FWCI
- 19.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- RiuNet (Universitat Politècnica de València) (submittedVersion, cc-by-nc-nd)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Secretaría de Estado de Investigación, Desarrollo e Innovación (MAT2015‐64139‐C4‐1‐R)
- H2020 European Research Council
- Instituto de Salud Carlos III (DTS16/00205)
- European Regional Development Fund
- European Social Fund
- Institut Ruđer Bošković
- Fundación Botín
- Banco Santander
- “la Caixa” Foundation
- Cancer Research UK (C9685‐A25177, RG86786)
- Generalitat Valenciana (PROMETEOII/2014/047)
- Pfizer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- senolytics, senescent cells, drug delivery systems, galactooligosaccharides, lysosomal beta-galactosidase, chemotherapy-induced senescence, palbociclib, age-related diseases
- MeSH terms
- Animals, beta-Galactosidase, Cell Survival, Cytotoxins, Disease Models, Animal, Drug Compounding, Fluorescent Dyes, Galactose, Lysosomes, Neoplasm Transplantation, Neoplasms, Oligosaccharides, Piperazines, Pyridines, Staining and Labeling, Drug Delivery Systems, Cellular Senescence, Mice, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A versatile drug delivery system targeting senescent cells. https://app.cochat.ai/papers/10.15252/emmm.201809355
- The paper
- Muñoz‐Espín, D., Rovira, M., Galiana, I., Giménez, C., Lozano‐Torres, B., Paez‐Ribes, M., Llanos, S., Chaib, S., Muñoz‐Martín, M., Ucero, A. C., Garaulet, G., Mulero, F., Dann, S. G., VanArsdale, T., Shields, D. J., Bernardos, A., Murguía, J. R., Martínez‐Máñez, R., & Serrano, M. (2018). A versatile drug delivery system targeting senescent cells. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.201809355
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.